|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1 to 100 out of 1159 for Ezh2

<< First    < Previous  |  Next >    Last >>
0.039s

Categories

Hits by Pathway

Hits by Strain

Hits by Category

Type Details Score
Gene
Type: gene
Organism: human
Gene
Type: gene
Organism: cattle
Gene
Type: gene
Organism: chicken
Gene
Type: gene
Organism: zebrafish
Gene
Type: gene
Organism: macaque, rhesus
Gene
Type: gene
Organism: frog, western clawed
Gene
Type: gene
Organism: rat
Gene
Type: gene
Organism: dog, domestic
Gene
Type: gene
Organism: chimpanzee
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Publication
First Author: Margueron R
Year: 2008
Journal: Mol Cell
Title: Ezh1 and Ezh2 maintain repressive chromatin through different mechanisms.
Volume: 32
Issue: 4
Pages: 503-18
Publication
First Author: O'Carroll D
Year: 2001
Journal: Mol Cell Biol
Title: The polycomb-group gene Ezh2 is required for early mouse development.
Volume: 21
Issue: 13
Pages: 4330-6
Gene
Type: gene
Organism: human
Publication
First Author: Han Z
Year: 2007
Journal: Structure
Title: Structural basis of EZH2 recognition by EED.
Volume: 15
Issue: 10
Pages: 1306-15
Publication
First Author: Caretti G
Year: 2004
Journal: Genes Dev
Title: The Polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation.
Volume: 18
Issue: 21
Pages: 2627-38
Publication
First Author: Shen X
Year: 2008
Journal: Mol Cell
Title: EZH1 mediates methylation on histone H3 lysine 27 and complements EZH2 in maintaining stem cell identity and executing pluripotency.
Volume: 32
Issue: 4
Pages: 491-502
Publication
First Author: Laible G
Year: 1999
Journal: Mamm Genome
Title: The murine polycomb-group genes Ezh1 and Ezh2 map close to Hox gene clusters on mouse chromosomes 11 and 6.
Volume: 10
Issue: 3
Pages: 311-4
Publication
First Author: Jin C
Year: 2017
Journal: Reproduction
Title: EZH2 deletion promotes spermatogonial differentiation and apoptosis.
Volume: 154
Issue: 5
Pages: 615-625
Publication
First Author: Mallen-St Clair J
Year: 2012
Journal: Genes Dev
Title: EZH2 couples pancreatic regeneration to neoplastic progression.
Volume: 26
Issue: 5
Pages: 439-44
Publication
First Author: Zhang J
Year: 2014
Journal: J Neurosci
Title: Ezh2 regulates adult hippocampal neurogenesis and memory.
Volume: 34
Issue: 15
Pages: 5184-99
Publication
First Author: Lund K
Year: 2014
Journal: Leukemia
Title: EZH2 in normal and malignant hematopoiesis.
Volume: 28
Issue: 1
Pages: 44-9
Publication
First Author: Jung HY
Year: 2013
Journal: Mol Cell
Title: PAF and EZH2 induce Wnt/β-catenin signaling hyperactivation.
Volume: 52
Issue: 2
Pages: 193-205
Publication  
First Author: Ni N
Year: 2022
Journal: Int J Mol Sci
Title: Role of EZH2 in Uterine Gland Development.
Volume: 23
Issue: 24
Publication    
First Author: Guo P
Year: 2024
Journal: Elife
Title: A methylation-phosphorylation switch controls EZH2 stability and hematopoiesis.
Volume: 13
Publication  
First Author: Hwang WW
Year: 2014
Journal: Elife
Title: Distinct and separable roles for EZH2 in neurogenic astroglia.
Volume: 3
Pages: e02439
Publication
First Author: Berg T
Year: 2014
Journal: Blood
Title: A transgenic mouse model demonstrating the oncogenic role of mutations in the polycomb-group gene EZH2 in lymphomagenesis.
Volume: 123
Issue: 25
Pages: 3914-24
Publication
First Author: Etchegaray JP
Year: 2006
Journal: J Biol Chem
Title: The polycomb group protein EZH2 is required for mammalian circadian clock function.
Volume: 281
Issue: 30
Pages: 21209-15
Publication
First Author: Su IH
Year: 2005
Journal: Cell
Title: Polycomb group protein ezh2 controls actin polymerization and cell signaling.
Volume: 121
Issue: 3
Pages: 425-36
Publication
First Author: Vasanthakumar A
Year: 2017
Journal: EMBO Rep
Title: A non-canonical function of Ezh2 preserves immune homeostasis.
Volume: 18
Issue: 4
Pages: 619-631
Publication
First Author: Kitchen GB
Year: 2021
Journal: FASEB J
Title: The histone methyltransferase Ezh2 restrains macrophage inflammatory responses.
Volume: 35
Issue: 10
Pages: e21843
Publication  
First Author: Patil S
Year: 2021
Journal: Cells
Title: Chromatin-Independent Interplay of NFATc1 and EZH2 in Pancreatic Cancer.
Volume: 10
Issue: 12
Publication
First Author: Hirukawa A
Year: 2018
Journal: Nat Commun
Title: Targeting EZH2 reactivates a breast cancer subtype-specific anti-metastatic transcriptional program.
Volume: 9
Issue: 1
Pages: 2547
Publication
First Author: Ahmed A
Year: 2018
Journal: PLoS One
Title: Ezh2 is not required for cardiac regeneration in neonatal mice.
Volume: 13
Issue: 2
Pages: e0192238
Publication  
First Author: Kobayashi Y
Year: 2021
Journal: Biochem Biophys Res Commun
Title: Ezh2 knockout in mesenchymal cells causes enamel hyper-mineralization.
Volume: 567
Pages: 72-78
Publication  
First Author: Jiang H
Year: 2023
Journal: Life Sci Alliance
Title: EZH2 controls epicardial cell migration during heart development.
Volume: 6
Issue: 6
Publication
First Author: Piper M
Year: 2014
Journal: J Neurosci
Title: NFIB-mediated repression of the epigenetic factor Ezh2 regulates cortical development.
Volume: 34
Issue: 8
Pages: 2921-30
Publication
First Author: Wang Y
Year: 2017
Journal: Int J Biol Sci
Title: Ezh2 Acts as a Tumor Suppressor in Kras-driven Lung Adenocarcinoma.
Volume: 13
Issue: 5
Pages: 652-659
Publication
First Author: Béguelin W
Year: 2013
Journal: Cancer Cell
Title: EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation.
Volume: 23
Issue: 5
Pages: 677-92
Publication
First Author: Caganova M
Year: 2013
Journal: J Clin Invest
Title: Germinal center dysregulation by histone methyltransferase EZH2 promotes lymphomagenesis.
Volume: 123
Issue: 12
Pages: 5009-22
Publication
First Author: Gu Z
Year: 2019
Journal: Cancer Discov
Title: Loss of EZH2 Reprograms BCAA Metabolism to Drive Leukemic Transformation.
Volume: 9
Issue: 9
Pages: 1228-1247
Publication  
First Author: Fang X
Year: 2022
Journal: Cells
Title: EZH2 and Endometrial Cancer Development: Insights from a Mouse Model.
Volume: 11
Issue: 5
Publication
First Author: Zhang X
Year: 2018
Journal: J Exp Med
Title: Macrophage/microglial Ezh2 facilitates autoimmune inflammation through inhibition of Socs3.
Volume: 215
Issue: 5
Pages: 1365-1382
Publication
First Author: Di Meglio T
Year: 2013
Journal: Science
Title: Ezh2 orchestrates topographic migration and connectivity of mouse precerebellar neurons.
Volume: 339
Issue: 6116
Pages: 204-7
Publication  
First Author: Deimling SJ
Year: 2018
Journal: Mech Dev
Title: Genetic interaction between Gli3 and Ezh2 during limb pattern formation.
Volume: 151
Pages: 30-36
Publication
First Author: Wang L
Year: 2010
Journal: Proc Natl Acad Sci U S A
Title: Histone H3K27 methyltransferase Ezh2 represses Wnt genes to facilitate adipogenesis.
Volume: 107
Issue: 16
Pages: 7317-22
Publication  
First Author: Wever I
Year: 2018
Journal: Front Mol Neurosci
Title: EZH2 Influences mdDA Neuronal Differentiation, Maintenance and Survival.
Volume: 11
Pages: 491
Publication
First Author: Schwarz D
Year: 2014
Journal: Development
Title: Ezh2 is required for neural crest-derived cartilage and bone formation.
Volume: 141
Issue: 4
Pages: 867-77
Publication
First Author: Snitow ME
Year: 2015
Journal: Development
Title: Ezh2 represses the basal cell lineage during lung endoderm development.
Volume: 142
Issue: 1
Pages: 108-17
Publication
First Author: Su IH
Year: 2003
Journal: Nat Immunol
Title: Ezh2 controls B cell development through histone H3 methylation and Igh rearrangement.
Volume: 4
Issue: 2
Pages: 124-31
Publication
First Author: Titelbaum M
Year: 2021
Journal: iScience
Title: Ezh2 harnesses the intranuclear actin cytoskeleton to remodel chromatin in differentiating Th cells.
Volume: 24
Issue: 10
Pages: 103093
Publication
First Author: Souroullas GP
Year: 2016
Journal: Nat Med
Title: An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylation.
Volume: 22
Issue: 6
Pages: 632-40
Publication  
First Author: Thulabandu V
Year: 2021
Journal: Dev Biol
Title: Dermal EZH2 orchestrates dermal differentiation and epidermal proliferation during murine skin development.
Volume: 478
Pages: 25-40
Publication
First Author: Wang D
Year: 2018
Journal: Cell Rep
Title: Targeting EZH2 Reprograms Intratumoral Regulatory T Cells to Enhance Cancer Immunity.
Volume: 23
Issue: 11
Pages: 3262-3274
Publication
First Author: Hou S
Year: 2019
Journal: J Exp Med
Title: FoxP3 and Ezh2 regulate Tfr cell suppressive function and transcriptional program.
Volume: 216
Issue: 3
Pages: 605-620
Publication
First Author: Tanaka S
Year: 2012
Journal: Blood
Title: Ezh2 augments leukemogenicity by reinforcing differentiation blockage in acute myeloid leukemia.
Volume: 120
Issue: 5
Pages: 1107-17
Publication
First Author: Baquero J
Year: 2021
Journal: Carcinogenesis
Title: EZH2 knockout in oral cavity basal epithelia causes more invasive squamous cell carcinomas.
Volume: 42
Issue: 12
Pages: 1485-1495
Publication
First Author: Minnebo N
Year: 2013
Journal: Nucleic Acids Res
Title: NIPP1 maintains EZH2 phosphorylation and promoter occupancy at proliferation-related target genes.
Volume: 41
Issue: 2
Pages: 842-54
Publication
First Author: Ma X
Year: 2017
Journal: Endocrinology
Title: Androgens Regulate Ovarian Gene Expression Through Modulation of Ezh2 Expression and Activity.
Volume: 158
Issue: 9
Pages: 2944-2954
Publication
First Author: Dhar S
Year: 2022
Journal: Acta Neuropathol Commun
Title: A tumor suppressor role for EZH2 in diffuse midline glioma pathogenesis.
Volume: 10
Issue: 1
Pages: 47
Publication
First Author: Simon C
Year: 2012
Journal: Genes Dev
Title: A key role for EZH2 and associated genes in mouse and human adult T-cell acute leukemia.
Volume: 26
Issue: 7
Pages: 651-6
Publication
First Author: Pasini D
Year: 2004
Journal: EMBO J
Title: Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity.
Volume: 23
Issue: 20
Pages: 4061-71
Publication
First Author: Nie L
Year: 2019
Journal: Nat Commun
Title: CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer.
Volume: 10
Issue: 1
Pages: 5114
Publication
First Author: Jacobsen JA
Year: 2017
Journal: J Immunol
Title: EZH2 Regulates the Developmental Timing of Effectors of the Pre-Antigen Receptor Checkpoints.
Volume: 198
Issue: 12
Pages: 4682-4691
Publication
First Author: Vo BT
Year: 2017
Journal: Cell Rep
Title: Inactivation of Ezh2 Upregulates Gfi1 and Drives Aggressive Myc-Driven Group 3 Medulloblastoma.
Volume: 18
Issue: 12
Pages: 2907-2917
Publication
First Author: Ningxia Z
Year: 2011
Journal: Anat Rec (Hoboken)
Title: The expression pattern of polycomb group protein Ezh2 during mouse embryogenesis.
Volume: 294
Issue: 7
Pages: 1150-7
Publication  
First Author: Luo Y
Year: 2022
Journal: Front Immunol
Title: EZH2 restricts Tcf7 DNA methylation and promotes TFH differentiation during acute viral infection.
Volume: 13
Pages: 942465
Publication
First Author: Basheer F
Year: 2019
Journal: J Exp Med
Title: Contrasting requirements during disease evolution identify EZH2 as a therapeutic target in AML.
Volume: 216
Issue: 4
Pages: 966-981
Publication
First Author: Qi W
Year: 2012
Journal: Proc Natl Acad Sci U S A
Title: Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation.
Volume: 109
Issue: 52
Pages: 21360-5
Publication
First Author: He S
Year: 2017
Journal: Nat Commun
Title: Ezh2 phosphorylation state determines its capacity to maintain CD8+ T memory precursors for antitumor immunity.
Volume: 8
Issue: 1
Pages: 2125
Publication  
First Author: Yang XP
Year: 2015
Journal: Sci Rep
Title: EZH2 is crucial for both differentiation of regulatory T cells and T effector cell expansion.
Volume: 5
Pages: 10643
Publication  
First Author: Sashida G
Year: 2014
Journal: Nat Commun
Title: Ezh2 loss promotes development of myelodysplastic syndrome but attenuates its predisposition to leukaemic transformation.
Volume: 5
Pages: 4177
Publication
First Author: Goswami S
Year: 2018
Journal: J Clin Invest
Title: Modulation of EZH2 expression in T cells improves efficacy of anti-CTLA-4 therapy.
Volume: 128
Issue: 9
Pages: 3813-3818
Publication
First Author: Kaneko S
Year: 2010
Journal: Genes Dev
Title: Phosphorylation of the PRC2 component Ezh2 is cell cycle-regulated and up-regulates its binding to ncRNA.
Volume: 24
Issue: 23
Pages: 2615-20
Publication
First Author: Piunti A
Year: 2022
Journal: Sci Adv
Title: Immune activation is essential for the antitumor activity of EZH2 inhibition in urothelial carcinoma.
Volume: 8
Issue: 40
Pages: eabo8043
Publication
First Author: Chibaya L
Year: 2023
Journal: Nat Cancer
Title: EZH2 inhibition remodels the inflammatory senescence-associated secretory phenotype to potentiate pancreatic cancer immune surveillance.
Volume: 4
Issue: 6
Pages: 872-892
Publication
First Author: Mochizuki-Kashio M
Year: 2011
Journal: Blood
Title: Dependency on the polycomb gene Ezh2 distinguishes fetal from adult hematopoietic stem cells.
Volume: 118
Issue: 25
Pages: 6553-61
Publication
First Author: Chen Y
Year: 2016
Journal: Front Med
Title: Spatiotemporal expression of Ezh2 in the developing mouse cochlear sensory epithelium.
Volume: 10
Issue: 3
Pages: 330-5
Publication
First Author: Wyngaarden LA
Year: 2011
Journal: Development
Title: Ezh2 regulates anteroposterior axis specification and proximodistal axis elongation in the developing limb.
Volume: 138
Issue: 17
Pages: 3759-67
Publication
First Author: Caviness PC
Year: 2023
Journal: FASEB J
Title: Decreased bone resorption in Ezh2 myeloid cell conditional knockout mouse model.
Volume: 37
Issue: 7
Pages: e23019
Publication  
First Author: Zhao L
Year: 2015
Journal: Sci Rep
Title: Ezh2 is involved in radial neuronal migration through regulating Reelin expression in cerebral cortex.
Volume: 5
Pages: 15484
Publication
First Author: Ezhkova E
Year: 2009
Journal: Cell
Title: Ezh2 orchestrates gene expression for the stepwise differentiation of tissue-specific stem cells.
Volume: 136
Issue: 6
Pages: 1122-35
Publication
First Author: Snitow M
Year: 2016
Journal: Development
Title: Ezh2 restricts the smooth muscle lineage during mouse lung mesothelial development.
Volume: 143
Issue: 20
Pages: 3733-3741
Publication
First Author: Wang L
Year: 2022
Journal: Nat Commun
Title: EZH2 depletion potentiates MYC degradation inhibiting neuroblastoma and small cell carcinoma tumor formation.
Volume: 13
Issue: 1
Pages: 12
Publication
First Author: Guo M
Year: 2018
Journal: J Immunol
Title: EZH2 Represses the B Cell Transcriptional Program and Regulates Antibody-Secreting Cell Metabolism and Antibody Production.
Volume: 200
Issue: 3
Pages: 1039-1052
Publication  
First Author: Lui JC
Year: 2016
Journal: Nat Commun
Title: EZH1 and EZH2 promote skeletal growth by repressing inhibitors of chondrocyte proliferation and hypertrophy.
Volume: 7
Pages: 13685
Publication
First Author: Yi SA
Year: 2016
Journal: Mol Cell
Title: S6K1 Phosphorylation of H2B Mediates EZH2 Trimethylation of H3: A Determinant of Early Adipogenesis.
Volume: 62
Issue: 3
Pages: 443-452
Publication  
First Author: Zingg D
Year: 2015
Journal: Nat Commun
Title: The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors.
Volume: 6
Pages: 6051
Publication
First Author: Lu W
Year: 2017
Journal: Oncogene
Title: SKP2 loss destabilizes EZH2 by promoting TRAF6-mediated ubiquitination to suppress prostate cancer.
Volume: 36
Issue: 10
Pages: 1364-1373
Publication
First Author: Michalak EM
Year: 2013
Journal: Stem Cells
Title: Polycomb group gene Ezh2 regulates mammary gland morphogenesis and maintains the luminal progenitor pool.
Volume: 31
Issue: 9
Pages: 1910-20
Publication
First Author: Tumes D
Year: 2019
Journal: J Allergy Clin Immunol
Title: Ezh2 controls development of natural killer T cells, which cause spontaneous asthma-like pathology.
Volume: 144
Issue: 2
Pages: 549-560.e10
Publication
First Author: Sashida G
Year: 2016
Journal: J Exp Med
Title: The loss of Ezh2 drives the pathogenesis of myelofibrosis and sensitizes tumor-initiating cells to bromodomain inhibition.
Volume: 213
Issue: 8
Pages: 1459-77
Publication
First Author: Zhang J
Year: 2022
Journal: Am J Pathol
Title: EZH2 Promotes Cholangiocarcinoma Development and Progression through Histone Methylation and microRNA-Mediated Down-Regulation of Tumor Suppressor Genes.
Volume: 192
Issue: 12
Pages: 1712-1724
Publication
First Author: Wang C
Year: 2012
Journal: Cancer Res
Title: EZH2 Mediates epigenetic silencing of neuroblastoma suppressor genes CASZ1, CLU, RUNX3, and NGFR.
Volume: 72
Issue: 1
Pages: 315-24
Publication
First Author: He S
Year: 2013
Journal: Blood
Title: The histone methyltransferase Ezh2 is a crucial epigenetic regulator of allogeneic T-cell responses mediating graft-versus-host disease.
Volume: 122
Issue: 25
Pages: 4119-28
Publication
First Author: Ferguson JW
Year: 2018
Journal: Dev Biol
Title: Stage-specific roles of Ezh2 and Retinoic acid signaling ensure calvarial bone lineage commitment.
Volume: 443
Issue: 2
Pages: 173-187
Publication
First Author: Li X
Year: 2009
Journal: Am J Pathol
Title: Targeted overexpression of EZH2 in the mammary gland disrupts ductal morphogenesis and causes epithelial hyperplasia.
Volume: 175
Issue: 3
Pages: 1246-54
Publication
First Author: Juan AH
Year: 2011
Journal: Genes Dev
Title: Polycomb EZH2 controls self-renewal and safeguards the transcriptional identity of skeletal muscle stem cells.
Volume: 25
Issue: 8
Pages: 789-94
Publication
First Author: DuPage M
Year: 2015
Journal: Immunity
Title: The chromatin-modifying enzyme Ezh2 is critical for the maintenance of regulatory T cell identity after activation.
Volume: 42
Issue: 2
Pages: 227-238
Publication
First Author: Cai H
Year: 2012
Journal: Cancer Res
Title: Collaboration of Kras and androgen receptor signaling stimulates EZH2 expression and tumor-propagating cells in prostate cancer.
Volume: 72
Issue: 18
Pages: 4672-81
Publication
First Author: Juan AH
Year: 2009
Journal: Mol Cell
Title: Mir-214-dependent regulation of the polycomb protein Ezh2 in skeletal muscle and embryonic stem cells.
Volume: 36
Issue: 1
Pages: 61-74